Profound Medical
PROF
44 hedge funds and large institutions have $75M invested in Profound Medical in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
13% more funds holding
Funds holding: 39 → 44 (+5)
0.49% less ownership
Funds ownership: 38.96% → 38.47% (-0.49%)
6% less capital invested
Capital invested by funds: $80.1M → $75M (-$5.16M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
75% less call options, than puts
Call options by funds: $10K | Put options by funds: $40K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$1.12M |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$713K |
| 3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$695K |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$542K |
| 5 |
Renaissance Technologies
New York
|
+$532K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$5.44M |
| 2 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$428K |
| 3 |
GS
Gagnon Securities
New York
|
-$373K |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$58.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$19.8K |
PROF Hedge Fund Activity: Q3 2024 in Review
44 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q3 2024, worth a combined $75M — down 6.4% from $80.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PROF positions and 4 closed out — a net gain of 5 holders — while 12 added to existing stakes and 8 trimmed.
The largest buyer was TD Asset Management, opening a new position worth an estimated $1.12M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $5.44M sold.
- 44 institutional investors held Profound Medical (PROF) as of Q3 2024, up from 39 in Q2 2024.
- Funds reported $75M of Profound Medical stock for Q3 2024, down 6.4% quarter-over-quarter.
- 9 funds opened new Profound Medical positions in Q3 2024 and 4 closed out, a net change of +5 holders.
- The largest Profound Medical buyer in Q3 2024 was TD Asset Management, an estimated $1.12M added.
- The largest Profound Medical seller in Q3 2024 was AIGH Capital Management, an estimated $5.44M sold.
Based on aggregated 13F filings for Q3 2024.